Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression.
Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression.
复制标题
DOI:
10.1158/2159-8290.cd-19-1299
复制
发表时间:
2020-03
期刊:
影响因子:
28.2
通讯作者:
Salina Yuan;Ramakrishnan Natesan;Francisco J. Sánchez-Rivera;Jinyang Li;N. Bhanu;Taiji Yamazoe;Jeffrey H. Lin;Allyson J Merrell;Yogev Sela;Stacy K. Thomas;Yanqing Jiang;Jacqueline B Plesset;E. M. Miller;Junwei Shi;B. Garcia;S. Lowe;I. Asangani;B. Stanger
中科院分区:
文献类型:
--
作者:
Salina Yuan;Ramakrishnan Natesan;Francisco J. Sánchez-Rivera;Jinyang Li;N. Bhanu;Taiji Yamazoe;Jeffrey H. Lin;Allyson J Merrell;Yogev Sela;Stacy K. Thomas;Yanqing Jiang;Jacqueline B Plesset;E. M. Miller;Junwei Shi;B. Garcia;S. Lowe;I. Asangani;B. Stanger
Epithelial plasticity - reversible modulation of a cell's epithelial and mesenchymal features - is associated with tumor metastasis and chemoresistance, leading causes of cancer mortality. While different master transcription factors and epigenetic modifiers have been implicated in this process in various contexts, the extent to which a unifying, generalized mechanism of transcriptional regulation underlies epithelial plasticity remains largely unknown. Here, through targeted CRISPR-Cas9 screening, we discovered two histone-modifying enzymes involved in the writing and erasing of H3K36me2 that act reciprocally to regulate epithelial-mesenchymal identity, tumor differentiation, and metastasis. Using a K-to-M histone mutant to directly inhibit H3K36me2, we found that global modulation of the mark is a conserved mechanism underlying the mesenchymal state in various contexts. Mechanistically, regulation of H3K36me2 reprograms enhancers associated with master regulators of epithelial-mesenchymal state. Our results thus outline a unifying epigenome-scale mechanism by which a specific histone modification regulates cellular plasticity and metastasis in cancer.